|View printer-friendly version|
|June 09, 2004 5:06 p.m.|
|Teva Announces Tentative Approval Of Carvedilol Tablets|
Jerusalem, Israel, June 9, 2004 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's ANDA for Carvedilol Tablets, 3.125 mg, 6.25 mg, 12.5 mg and 25 mg. Final approval is anticipated upon expiry of patent protection for the brand product on March 5, 2007.